TransMedics Group, Inc. is a medical device company headquartered in Andover, Massachusetts, that specializes in advanced organ preservation and transport systems for transplantation. The company’s flagship technology, the Organ Care System (OCS), maintains donor organs in a near-physiologic, warm, beating state during transportation, with the aim of extending preservation times and improving post‐transplant outcomes. TransMedics’ solutions address a critical need in transplantation by reducing ischemic injury and expanding the donor organ pool.
TransMedics currently markets two commercially available OCS platforms. The OCS Heart system is approved by the U.S. Food and Drug Administration (FDA) and has received CE Mark clearance in Europe for heart transplantation. By maintaining the donor heart in a perfused, beating state outside the body, the system allows clinicians to assess organ function prior to implantation. The OCS Lung platform similarly supports donor lungs with normothermic perfusion and has FDA approval and CE Mark clearance for clinical use.
In addition to its heart and lung preservation products, TransMedics is developing an investigational OCS Liver system designed to extend preservation times and improve viability assessments for donor livers. The company is conducting clinical trials globally to evaluate safety and efficacy, with the goal of securing regulatory approvals in key markets. TransMedics maintains commercial operations in North America and Europe and is working to expand its footprint in Asia-Pacific and other regions.
Leadership at TransMedics includes Waleed Hassanein, M.D., who serves as President and Chief Executive Officer. Dr. Hassanein brings extensive experience in the medical device industry, having led global commercial and clinical strategy teams prior to joining the company. Under his direction, TransMedics continues to invest in research and development, partnering with transplant centers and research institutions to advance organ care technologies and address the growing need for viable donor organs worldwide.
AI Generated. May Contain Errors.
